Clinical Trials in Dallas

Showing 1081-1100 of 17,468 trials

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome

NCT06118255

The primary purpose of this study is evaluate the safety and tolerability of fenfluramine hydrochloride (HCl) 0.2 to 0.8 mg/kg/day in infants 1 year to less than 2 years of age with Dravet syndrome.

Dravet Syndrome

UCB BIOSCIENCES, Inc.25 participantsStarted May 2024

Memphis, Tennessee, United States • Dallas, Texas, United States • Seattle, Washington, United States +9 more locations

Active Not RecruitingPhase 3< 1 mile

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634

Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures

Partial Epilepsy

SK Life Science, Inc.140 participantsStarted Jan 2022

Phoenix, Arizona, United States • Palo Alto, California, United States • Sacramento, California, United States +51 more locations

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Find Trials by Condition in Dallas

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

A Study of LY4060874 in Healthy Participants

AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

The Purpose of This Study is to Evaluate the Safety and Efficacy of D-MNA in Adult Patients With Nodular Basal Cell Carcinoma

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

The Lilac Device Trial

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD

Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia